Results 11 to 20 of about 39,340 (291)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

open access: yesThrombosis Journal, 2021
Background Recently, direct oral anticoagulants (DOACs) have been included in guidelines for the treatment of cancer-associated thrombosis (CAT) to be extended to suitable cancer patients.
Kaidireyahan Wumaier   +3 more
doaj   +1 more source

Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis.

open access: yesPLoS ONE, 2022
Background and aimCOVID-19 pandemic burdens the healthcare systems, causes healthcare avoidance, and might worsen the outcomes of inflammatory bowel disease (IBD) management. We aimed to estimate the impact of pandemic-related avoidance on outpatient IBD
Jiaqi Yao   +3 more
doaj   +1 more source

QALYs: The Basics

open access: yesValue in Health, 2009
The aim of this article is to review the concept of the qualityadjusted life-year (QALY), a widely used measure of health improvement that is used to guide health-care resource allocation decisions. The QALY was originally developed as a measure of health effectiveness for cost-effectiveness analysis, a method intended to aid decision-makers charged ...
Weinstein, Milton C.   +2 more
openaire   +2 more sources

A QALY is [still] a QALY is [still] a QALY?

open access: yesBMC Medical Ethics
Abstract Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained. This paper, taking an ethical stand, reevaluates the standard cost-effectiveness analysis with that of the more recent justice-enhanced methods and ...
Mahdiani, Hamideh   +2 more
openaire   +4 more sources

Quality-adjusted life years for digital cognitive behavioural therapy for insomnia (Sleepio): a secondary analysis

open access: yesBJGP Open, 2022
Background: Insomnia is common, and difficulty with daytime functioning is a core symptom. Studies show cognitive behavioural therapy (CBT) improves functioning, but evidence is needed on its value for money.
Elizabeth A Stokes   +4 more
doaj   +1 more source

Personal and societal health quality lost to tuberculosis.

open access: yesPLoS ONE, 2009
BackgroundIn developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare.
Thaddeus L Miller   +4 more
doaj   +1 more source

Problems and solutions in calculating quality-adjusted life years (QALYs)

open access: yesHealth and Quality of Life Outcomes, 2003
The quality-adjusted life-year (QALY) is a measure of the value of health outcomes. Since health is a function of length of life and quality of life, the QALY was developed as an attempt to combine the value of these attributes into a single index number.
Sacristán José A, Prieto Luis
doaj   +1 more source

Estimated Impact of Deemed Consent Legislation for Organ Donation on Individuals With Kidney Failure: A Dynamic Decision Analytic Model

open access: yesCanadian Journal of Kidney Health and Disease, 2022
Background: There is little data modeling the impact of deemed consent legislation (eligible individuals who do not register their decision to decline to be a donor are presumed to consent after death) on outcomes for individuals with kidney failure ...
Koto P.   +7 more
doaj   +1 more source

Calculating QALYs, comparing QALY and DALY calculations [PDF]

open access: yesHealth Policy and Planning, 2006
Quality-adjusted life years (QALYs) have been used in the assessment of health interventions for three decades. The popularity of the QALY approach has been constantly increasing, although the debate on its theoretical underpinnings and practical implications is still ongoing.
openaire   +2 more sources

Home - About - Disclaimer - Privacy